SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricors upcoming FDA decision on deramiocel for Duchenne muscular dystrophy is the dominant focus, with traders reading managements confidence and comments about labeling as encouraging ahead of the review outcome. Many are bullish and anticipate a short squeeze, while others stress that approval is uncertain and a rejection remains a risk.

RUM Group, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

RUM Group Inc. - Ordinary Shares - Class A

RUM Group Inc.

Rumbles Q3 resultsrecord revenue and its first positive adjusted EBITDA, driven largely by Quake AIhave put its AI-infrastructure pivot in focus. Bulls see evidence the expansion is gaining traction and speculate heavy short interest could amplify the rally, while skeptics point to ongoing losses, financing needs and data-center delays.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerrys QNX automotive-software partnerships are driving discussion, particularly its Valeo smart-camera collaboration and design wins in China, alongside traders enthusiasm about the AMD relationship. Bulls see these as signs of expanding automotive and robotics opportunities, while skeptics point to resistance near recent highs and question when design wins and backlog will translate into revenue.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is drawing attention in a broad AI-chip rebound after CoreWeaves results renewed confidence in AI infrastructure demand, with traders also citing rotation away from Nvidia amid its recent weakness. The sharp bounce has fueled bullish momentum and short-squeeze talk, while skeptics warn it may be overextended and vulnerable to a pullback.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

CoreWeaves strong results and raised outlook have lifted sentiment across AI cloud providers, driving a rally in Nebius shares ahead of its own quarterly report. Traders are betting on sustained compute demand and a strong Nebius update, while others caution that the run-up raises expectations and that financing and expansion execution remain key risks.

Boost Run, Inc. is a provider of scalable cloud infrastructure purpose-built for enterprise AI and high-performance computing workloads. The platform delivers GPU compute, CPU nodes, managed Kubernetes orchestration, and shared storage through an intuitive management console and a robust API layer, enabling organizations to provision and scale resources across thousands of nodes in minutes. The company was founded on September 5, 2025 and is headquartered in Northbrook, IL.

Boost Run Inc. - Ordinary Shares - Class A

Boost Run Inc.

Boost Runs five-year AI cloud services contract, powered by NVIDIA GPUs, is driving renewed interest and a sharp rebound after a steep selloff. Bulls view the deal as validation of demand, while skeptics say the company still needs to turn its contracted business into revenue and cash flow, with upcoming quarterly results seen as an important test.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

A quarterly earnings beat, raised outlook and strong AI-compute demand sparked a sharp rebound, with traders also pointing to customer prepayments and the CEOs canceled stock-sale plan as easing funding concerns. Bulls see potential for a short squeeze, while skeptics remain focused on heavy debt, interest costs, capital spending and dilution risk.

Netlist, Inc. engages in the design, manufacture and sale of memory subsystems for the computing and communications markets. Its products include enterprise SSD, embedded flash, memory module, lightning DDR5 DIMM, SK hynix, AI server. The company was founded by Jayesh Bhakta, Chun Ki Hong and Christopher Lopes in June 2000 and is headquartered in Irvine, CA.

Netlist Inc

Netlists quarterly results and earnings call are driving attention: traders debate the post-report decline and apparent earnings miss, with many attributing the gap to Samsungs upfront license payment being recognized over the agreement term. Bulls point to recurring Samsung and Micron licensing revenue and managements hint that SK Hynix could be a next licensing partner, while skeptics cite the lack of a confirmed Hynix deal or Nasdaq uplisting update.

Direxion Shares ETF Trust - Direxion Daily MU Bull 2X ETF

Direxion Daily MU Bull 2X Shares

MUU is drawing attention as a 2x leveraged Micron fund amid sharp swings in Micron and memory-chip stocks. Traders cite Microns earnings and AI-related memory demand as reasons to buy dips, while others warn that sector weakness and leverage can amplify losses.

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. Its products include Gvoke, Keveyis, and Recorlev. Gvoke is a ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Xeris Biopharma Holdings Inc

Strong Q3 growth, raised revenue outlook and accelerating demand for Recorlev are driving a bullish rerating discussion, reinforced by analyst upgrades. Traders are celebrating the move, while some question whether the valuation has run ahead of fundamentals; buyout chatter is speculative.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
